The Role for Systematic Biopsy Plus MRI-Targeted Procedures

EP: 1.The Role of Imaging in Diagnosing and Staging Prostate Cancer

EP: 2.Advances in Prostate Biopsy

EP: 3.Benefits of Incorporating Fusion-Guided Biopsy into Practice

EP: 4.A Review of the Data for Fusion-Based Biopsy Procedures

EP: 5.Understanding Differences in Fusion-Guided Biopsy Technologies

Now Viewing

EP: 6.The Role for Systematic Biopsy Plus MRI-Targeted Procedures

EP: 7.Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer

EP: 8.Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy

EP: 9.Incorporating Fusion-Guided Biopsy to Practice

EP: 10.Future Directions for Imaging and Biopsy in Prostate Cancer

EP: 11.The Impact of MRI-Guided Biopsy in Diagnosis and Treatment Decisions

EP: 12.Overcoming Limitations of Traditional Biopsies with MRI-Guided Biopsies

EP: 13.An Overview of Fusion-Guided Systems

EP: 14.Fusion-Based Biopsies in Active Surveillance

EP: 15.Expert Insights on MRI-US Fusion-Guided Biopsy

EP: 16.The Impact of Fusion-Guided Biopsy on Focal Therapy in Prostate Cancer

EP: 17.Looking Ahead: Image-Guided Diagnostic Tools

Video content above is prompted by the following questions:

• What are some of the key differences between organ-based tracking and probe tracking technologies used in the current fusion-guided platforms? How do these differences impact the procedural workflow or your approach to these procedures?
• How do fusion-guided and MRI-targeted biopsy options compare? What are some of the key differences between MRI/US fusion-guided elastic biopsy and MRI-targeted biopsy?